Yu J, Hong K, Yao L, Shi D, Zhang J
Discov Oncol. 2025; 16(1):147.
PMID: 39928209
PMC: 11810858.
DOI: 10.1007/s12672-025-01755-5.
Filipovich E, Gorodkova E, Shcherbakova A, Asaad W, Popov S, Melnichenko G
Heliyon. 2025; 11(1):e41457.
PMID: 39834406
PMC: 11742855.
DOI: 10.1016/j.heliyon.2024.e41457.
Teodoro L, Carreira A, Sogayar M
Breast Cancer (Dove Med Press). 2024; 16:913-934.
PMID: 39691553
PMC: 11651076.
DOI: 10.2147/BCTT.S489246.
Celada S, Li G, Celada L, Kanagasabai T, Lu W, Brown L
Sci Signal. 2024; 17(867):eadk4122.
PMID: 39689183
PMC: 11784317.
DOI: 10.1126/scisignal.adk4122.
Yang J, Zhong B, Yang L, Luo Z, Jia L, Zheng K
Genes (Basel). 2024; 15(11).
PMID: 39596659
PMC: 11593471.
DOI: 10.3390/genes15111459.
Inhibition of DNA Topoisomerase Ι by Flavonoids and Polyacetylenes Isolated from L.
Zeng G, Wang Y, Zhu M, Yi J, Ma J, Yang B
Molecules. 2024; 29(15).
PMID: 39124952
PMC: 11314063.
DOI: 10.3390/molecules29153547.
MDM2: current research status and prospects of tumor treatment.
Yao Y, Zhang Q, Li Z, Zhang H
Cancer Cell Int. 2024; 24(1):170.
PMID: 38741108
PMC: 11092046.
DOI: 10.1186/s12935-024-03356-8.
Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs.
Rej R, Rao Allu S, Roy J, Acharyya R, Kiran I, Addepalli Y
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675453
PMC: 11054475.
DOI: 10.3390/ph17040494.
P53-Independent G1-Cell Cycle Arrest Increases SARS-CoV-2 RNA Replication.
Husser C, Kwon H, Andersson K, Appelberg S, Montserrat N, Mirazimi A
Microorganisms. 2024; 12(3).
PMID: 38543494
PMC: 10972258.
DOI: 10.3390/microorganisms12030443.
Hippo cooperates with p53 to maintain foregut homeostasis and suppress the malignant transformation of foregut basal progenitor cells.
Jiang Y, Huang H, Liu J, Luo D, Mu R, Yuan J
Proc Natl Acad Sci U S A. 2024; 121(10):e2320559121.
PMID: 38408237
PMC: 10927585.
DOI: 10.1073/pnas.2320559121.
Power-law behavior of transcriptional bursting regulated by enhancer-promoter communication.
Wang Z, Zhang Z, Luo S, Zhou T, Zhang J
Genome Res. 2024; 34(1):106-118.
PMID: 38171575
PMC: 10903953.
DOI: 10.1101/gr.278631.123.
Human Intestinal Organoids and Microphysiological Systems for Modeling Radiotoxicity and Assessing Radioprotective Agents.
Bouges E, Segers C, Leys N, Lebeer S, Zhang J, Mastroleo F
Cancers (Basel). 2023; 15(24).
PMID: 38136404
PMC: 10741417.
DOI: 10.3390/cancers15245859.
Silver Nanoparticles (AgNPs) as Enhancers of Everolimus and Radiotherapy Sensitivity on Clear Cell Renal Cell Carcinoma.
Morais M, Machado V, Figueiredo P, Dias F, Craveiro R, Lencart J
Antioxidants (Basel). 2023; 12(12).
PMID: 38136171
PMC: 10741111.
DOI: 10.3390/antiox12122051.
4D nucleome equation predicts gene expression controlled by long-range enhancer-promoter interaction.
Wang Z, Luo S, Zhang Z, Zhou T, Zhang J
PLoS Comput Biol. 2023; 19(12):e1011722.
PMID: 38109463
PMC: 10760824.
DOI: 10.1371/journal.pcbi.1011722.
Nutrient-Based Approaches for Melanoma: Prevention and Therapeutic Insights.
Dong Y, Wei J, Yang F, Qu Y, Huang J, Shi D
Nutrients. 2023; 15(20).
PMID: 37892558
PMC: 10609833.
DOI: 10.3390/nu15204483.
The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases.
Liang X, Dai Z, Zou R, Tang J, Yao C
Int J Mol Sci. 2023; 24(17).
PMID: 37686364
PMC: 10487876.
DOI: 10.3390/ijms241713558.
Artichoke as a melanoma growth inhibitor.
Mathew A, Deng Z, Nelson C, Mayberry T, Bai Q, Lequio M
Med Oncol. 2023; 40(9):262.
PMID: 37544953
DOI: 10.1007/s12032-023-02077-8.
Tasmanian devil cathelicidins exhibit anticancer activity against Devil Facial Tumour Disease (DFTD) cells.
Petrohilos C, Patchett A, Hogg C, Belov K, Peel E
Sci Rep. 2023; 13(1):12698.
PMID: 37542170
PMC: 10403513.
DOI: 10.1038/s41598-023-39901-0.
DPY30 Promotes Proliferation and Cell Cycle Progression of Colorectal Cancer Cells via Mediating H3K4 Trimethylation.
Su W, Mao X, Li S, Luo C, Fan R, Jiang H
Int J Med Sci. 2023; 20(7):901-917.
PMID: 37324189
PMC: 10266052.
DOI: 10.7150/ijms.80073.
MDM2 Implications for Potential Molecular Pathogenic Therapies of Soft-Tissue Tumors.
Sun S, Crago A
J Clin Med. 2023; 12(11).
PMID: 37297833
PMC: 10253559.
DOI: 10.3390/jcm12113638.